[Using medical imaging for a comprehensive breast cancer screening program].
We described here the national breast cancer-screening program that is used, in France, today. First we depict official rules and regulations along with the organization needed to screen a whole population. Then, a technical assessment is made on the efficacy and limits on mammography analyses leading to tumor classification. Finally, an evaluation of the program is discussed.
Dilhuydy
M-H
MH
Institut Bergonié, 229, cours de L'argonne, 33000 Bordeaux, France. mh.dilhuydy@orange.fr
D000367:Age Factors; D000368:Aged; D001706:Biopsy; D001940:Breast / Q000473:pathology; D001943:Breast Neoplasms / Q000175:diagnosis* / Q000401:mortality / Q000473:pathology; D055088:Early Detection of Cancer / Q000379:methods; D005260:Female; D005602:France / Q000453:epidemiology; D006801:Humans; D008327:Mammography / Q000009:adverse effects / Q000145:classification; D008403:Mass Screening / Q000331:legislation & jurisprudence / Q000379:methods* / Q000458:organization & administration; D008875:Middle Aged; D009313:National Health Programs / Q000331:legislation & jurisprudence / Q000458:organization & administration*; D011159:Population Surveillance / Q000379:methods; D015397:Program Evaluation; D011786:Quality Control